|
PHF12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.321840E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.212400E-02 |
| Normal-vs-Stage2 |
3.928400E-01 |
| Normal-vs-Stage3 |
1.463710E-03 |
| Normal-vs-Stage4 |
2.962400E-02 |
| Stage1-vs-Stage2 |
3.638000E-01 |
| Stage1-vs-Stage3 |
8.629600E-02 |
| Stage1-vs-Stage4 |
6.532000E-01 |
| Stage2-vs-Stage3 |
5.104500E-02 |
| Stage2-vs-Stage4 |
2.829200E-01 |
| Stage3-vs-Stage4 |
4.057600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.539000E-03 |
| Normal-vs-AfricanAmerican |
6.060600E-01 |
| Normal-vs-Asian |
2.506800E-01 |
| Caucasian-vs-AfricanAmerican |
2.092200E-01 |
| Caucasian-vs-Asian |
3.015400E-01 |
| AfricanAmerican-vs-Asian |
6.874400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.962400E-02 |
| Normal-vs-Female |
9.142800E-03 |
| Male-vs-Female |
3.285000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.218100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.339500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.383780E-02 |
| Normal-vs-Age(81-100Yrs) |
7.341900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.544600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.462400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.620600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.550400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.236600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.142800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.941500E-03 |
| Classical-VS-Follicular |
4.948400E-01 |
| Classical-VS-Other |
4.148800E-01 |
| Classical-VS-Normal |
7.473800E-02 |
| Tall-VS-Follicular |
2.232300E-02 |
| Tall-VS-Other |
4.461200E-01 |
| Tall-VS-Normal |
1.222230E-04 |
| Follicular-VS-Other |
6.819000E-01 |
| Follicular-VS-Normal |
8.207800E-02 |
| Other-VS-Normal |
1.774190E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.220000E-02 |
| Normal-vs-N1 |
2.217500E-02 |
| N0-vs-N1 |
5.786200E-01 |
|
|
